Cipla Limited (NSE:CIPLA)

Market Cap	1.06T
Revenue (ttm)	279.67B
Net Income (ttm)	45.46B
Shares Out	807.77M
EPS (ttm)	56.25
PE Ratio	23.38
Forward PE	26.73
Dividend	13.00 (0.99%)
Ex-Dividend Date	Jun 27, 2025

Volume	6,590,032
Average Volume	2,165,186
Open	1,372.20
Previous Close	1,370.40
Day's Range	1,303.00 - 1,385.90
52-Week Range	1,303.00 - 1,673.00
Beta	0.04
RSI	16.66
Earnings Date	Jan 23, 2026

About Cipla

Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer’s disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obe...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1935
• Employees: 30,313
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: CIPLA

Financial Performance

In 2024, Cipla's revenue was 272.67 billion, an increase of 6.78% compared to the previous year's 255.37 billion. Earnings were 52.73 billion, an increase of 27.93%.